• Poster

Pharmaceutical Benefit-Risk Assessment: What Should We Do in the Absence of Regulatory Guidance?

Citation

Garrison, L., Levitan, B., & Johnson, F. R. (2011, June). Pharmaceutical Benefit-Risk Assessment: What Should We Do in the Absence of Regulatory Guidance?. Presented at ISPOR 16th Annual International Meeting, .

Abstract